Today in News History
On July 12, several notable moments in the history of News stand out. In 1925, Albert Lance, Australian-French tenor (died 2013) was born. In 1928, Alastair Burnet, English journalist (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1938, Eiko Ishioka, Japanese art director and graphic designer (died 2012) was born. In 1944, Delia Ephron, American author, playwright, and screenwriter was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 1995, Evania Pelite, Australian rugby union player was born. In 2006, The 2006 Lebanon War begins. In 2014, Jamil Ahmad, Pakistani author (born 1931) passed away. In 2024, Evan Wright, American writer (born 1964) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Ionis’ eplontersen fails primary endpoint in heart disease trial
Narrative Intelligence Brief
This article was published by Investing.com, a source frequently categorized with a center bias based in Israel. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Investing.com, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Investing.com
July 12, 2026
Lindsey Graham, pivotal US Republican senator, dies suddenly at 71
July 12, 2026
Is AI making markets more or less efficient?
July 12, 2026
Lindsey Graham dies at 71 after brief illness, leaving vacancy in U.S. Senate
July 12, 2026
Volkswagen "Future Plan" announced: Is this the right way to go?
July 12, 2026
South China Sea joint statement says China’s maritime claims have no basis
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinal"
Argentina beat Switzerland to set up World Cup semifinal against England
[Photo] JUST IN: 🇦🇷 Argentina officially advances to the FIFA World Cup semifinal after defeat [...]
Argentina set up titanic World Cup semifinal against England with extra-time victory over Switzerland after Breel Embolo's embarrassing red card
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 0%
Center 33%
Right 67%
Investing.com
· Jun 29, 2026
Evommune’s EVO756 fails phase 2b trial in chronic urticaria
Evommune’s EVO756 fails phase 2b trial in chronic urticaria
The News Letter
· Jun 26, 2026
Avinox wins Eurobike 2026 Award with its smart heart rate control system
The system is set to be a ‘genuine game changer’.
The Economic Times
· Jul 9, 2026
5 tests to detect heart attacks: Dr. Devi Shetty
5 tests to detect heart attacks: Dr. Devi Shetty
Medical Daily
· Jul 7, 2026
The Clinical Trial That Supported Tavneos for ANCA Vasculitis Was Just Retracted
NEJM retracted the Tavneos ADVOCATE trial on June 29, 2026, after FDA found altered patient data. Patients should not stop Tavneos without a doctor — here's what's known.
Perfect Health Diet
· Aug 8, 2024
Angiex Doses First Patient in Clinical Trial of AGX101!
I’m pleased to announce that Angiex has dosed the first patient in our Phase 1 clinical trial of AGX101, Angiex’s lead drug. As some of you know, 9 years ago Shou-Ching and I suspended our blog and health retreat to Read more » The post Angiex Doses First Patient in Clinical Trial of AGX101! appeared first on Perfect Health Diet.
Independent Journal Review
· Jul 1, 2026
AI Company Anthropic Unveils New Drug Discovery Program
Anthropic announced Tuesday that it is launching new pre-clinical drug discovery programs in an attempt to produce artificial intelligence-powered tools for drugmakers.
Topics:
Related coverage for "Ionis’ eplontersen fails primary endpoint in heart disease trial": Investing.com — Evommune’s EVO756 fails phase 2b trial in chronic urticaria. The News Letter — Avinox wins Eurobike 2026 Award with its smart heart rate control system. The Economic Times — 5 tests to detect heart attacks: Dr. Devi Shetty . Medical Daily — The Clinical Trial That Supported Tavneos for ANCA Vasculitis Was Just Retracted. Perfect Health Diet — Angiex Doses First Patient in Clinical Trial of AGX101!. Independent Journal Review — AI Company Anthropic Unveils New Drug Discovery Program